Detalles de la búsqueda
1.
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile.
Antimicrob Agents Chemother;
68(3): e0162123, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364016
2.
The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic.
Antimicrob Agents Chemother;
67(5): e0156322, 2023 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37093023
3.
Fusobacteria behaving badly: Masquerading strains of strictly anaerobic Escherichiacoli misidentified due to the deletion of the hemB gene.
Anaerobe;
79: 102682, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580991
4.
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection.
Antimicrob Agents Chemother;
66(8): e0224421, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862742
5.
Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
Anaerobe;
72: 102440, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34461273
6.
Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores.
Anaerobe;
69: 102352, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33640461
7.
Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
Anaerobe;
70: 102387, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34044101
8.
In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile.
Antimicrob Agents Chemother;
64(8)2020 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32513796
9.
In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.
J Antimicrob Chemother;
75(10): 2879-2884, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719870
10.
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects.
J Antimicrob Chemother;
75(12): 3635-3643, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892222
11.
Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.
Anaerobe;
61: 102081, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31356958
12.
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge.
Clin Infect Dis;
68(11): 1887-1893, 2019 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30204878
13.
Activity of Hospital Disinfectants against Vegetative Cells and Spores of Clostridioides difficile Embedded in Biofilms.
Antimicrob Agents Chemother;
64(1)2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31611365
14.
Molecular epidemiology of Clostridioides difficile in domestic dogs and zoo animals.
Anaerobe;
59: 107-111, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207298
15.
Clostridioides difficile ribotypes isolated from domestic environment and from patients in Bangladesh.
Anaerobe;
56: 88-90, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30794875
16.
Accelerate PhenoTestTM BC Kit Versus Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram-Positive Bloodstream Isolates: Potential Implications for Antimicrobial Stewardship.
Ann Pharmacother;
52(8): 754-762, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29557208
17.
Novel antibiotics in development to treat Clostridium difficile infection.
Curr Opin Gastroenterol;
33(1): 1-7, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28134686
18.
Clinical use comparison of a semiautomated PCR with fluorescent ribotyping for typing of Clostridium difficile.
Arch Microbiol;
199(2): 317-323, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27730251
19.
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes.
Antimicrob Agents Chemother;
60(6): 3519-23, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27021314
20.
Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection.
J Antimicrob Chemother;
71(5): 1245-51, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26895772